RIO DE JANEIRO, Jan. 12 /PRNewswire-FirstCall/ -- Amilpar (BOVESPA: AMIL3, Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3 SA), the largest managed care organization in Brazil, in accordance with CVM (Brazilian Securities and Exchange Commission) Instruction 358/02, informs that was approved in Board Meeting held today, the 1st Issuance of Debentures for public distribution with restricted selling efforts (according to CVM Instruction 476/09), with the objective of increase Company's cash position after the acquisition of Medial Saude S.A. control, under the following terms and conditions:
Total Amount: R$ 300 million Term: 360 days, with the option of anticipating redemption after 180 days Remuneration: 109.75% of CDI (average interbank deposit rate in Brazil) Issuance: January 26, 2010 Coordinators: Banco Itau BBA S.A. e HSBC CTVM S.A. To access the .pdf version, visit our website at http://www.amilpar.com.br/ir. IR Contacts: Investor Relations Phone.: +55 (21) 3805-1155 E-mail: invest@amil.com.br http://www.amilpar.com.br/ir
Amilpar
CONTACT: Erwin Kleuser, investor relations, Amilpar,
+011-5521-3805-1155, invest@amil.com.br
Web site: http://www.amilpar.com.br/ir
